Who
Alan Glicklich
Director
Company insider
Files Form 4 as: Director, CalciMedica; Chief Medical Officer, Chinook Therapeutics.
In numbers
- Trades disclosed
- 23
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $357K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 5 Oct 2020
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 13 Oct 2025filed 14 Oct 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —937 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,166 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 Jan 2025filed 16 Jan 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 11 Feb 2022filed 14 Feb 2022 | Chinook Therapeutics | SEC FORM 4 Sold | $30K2,391 at $12.74 | filing |
| 10 Feb 2022filed 14 Feb 2022 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code M | —5,668 at $0.00 | filing |
| 10 Feb 2022filed 14 Feb 2022 | Chinook Therapeutics | SEC FORM 4 Code M | —5,668 | filing |
| 6 Oct 2021filed 8 Oct 2021 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code M | —7,103 at $0.00 | filing |
| 6 Oct 2021filed 8 Oct 2021 | Chinook Therapeutics | SEC FORM 4 Code M | —7,103 | filing |
| 6 Oct 2021filed 8 Oct 2021 | Chinook Therapeutics | SEC FORM 4 Code F | $31K2,489 at $12.37 | filing |
| 16 Jun 2021filed 17 Jun 2021 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 16 Jun 2021filed 17 Jun 2021 | Chinook Therapeutics | SEC FORM 4 Code M | $8,40020,000 at $0.42 | filing |
| 16 Jun 2021filed 17 Jun 2021 | Chinook Therapeutics | SEC FORM 4 Sold | $327K20,000 at $16.35 | filing |
| 10 Feb 2021filed 12 Feb 2021 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 10 Feb 2021filed 12 Feb 2021 | Chinook Therapeuticsoption or derivative | SEC FORM 4 Code A | —17,005 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.